Shares of Palatin Technologies Inc. rocketed 27% in very active premarket trading Monday, after a positive Food and Drug Administration decision on AMAG...
Shares of Palatin Technologies Inc. PTN, +4.69% rocketed 27% in very active premarket trading Monday, after a positive Food and Drug Administration decision on
, +4.06% treatment for hypoactive sexual desire disorder triggered a $60 million milestone payment. Trading volume was over 2.9 million shares, making Palatin's stock the most actively traded ahead of the open. The FDA granted marketing approval for 's stock surged 8.1% ahead of the open. The company expects to receive the milestone payment in July. Based on the license agreement with
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Vyleesi: New drug for women with low sex drive gets FDA approvalThe FDA has approved a new medication that will boost libido in women with low sexual desire, so that they too can have an enjoyable sex life.
Baca lebih lajut »
The Desire For Desire: On-Demand Female Sex Drive Drug ApprovedIt may revive the 'little pink pill' debate about female sexuality, but the new drug is actually an injectable much like an epi-Pen, meant to be taken at least 45 minutes before sex.
Baca lebih lajut »
The Desire For Desire: On-Demand Female Sex Drive Drug ApprovedIt may revive the 'little pink pill' debate about female sexuality, but the new drug is actually an injectable much like an epi-Pen, meant to be taken at least 45 minutes before sex.
Baca lebih lajut »
Believing all this talk about a stock market bubble can land you in real troubleS&P 500 gains aren’t large enough to prove the market is overheated, writes Mark Hulbert.
Baca lebih lajut »
[Self-Test] Generalized Anxiety Disorder in AdultsIf you have generalized anxiety disorder, you worry about everything — whether appropriate and necessary or not. Symptoms of anxiety are nearly constant — and often blown out of proportion when compared to their causes.
Baca lebih lajut »